Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

2003 • 274 citations

COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY

1992 • 231 citations

Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer

2002 • 205 citations

A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-Guerin

1996 • 197 citations

A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

2007 • 193 citations

HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

2005 • 185 citations

Complications of Intravesical Therapy for Urothelial Cancer of the Bladder

2006 • 185 citations

The Effect of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients With Superficial Bladder Cancer: Results of a Randomized, Prospective, Double-Blind, Placebo Controlled, Multicenter Study

2006 • 171 citations

BCG Intravesical Instillations: Recommendations for Side-Effects Management

2000 • 159 citations

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

2001 • 140 citations

COMPLICATIONS OF INTRAVESICAL CHEMOTHERAPY

1992 • 118 citations

A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma

1996 • 110 citations

Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer

2001 • 90 citations

Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911

1997 • 85 citations

Systemic Bacillus Calmette-Guérin Infection, ‘BCGitis’, in Patients Treated by Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer

1989 • 81 citations

Sensitivity of BCG to Modern Antibiotics

2000 • 62 citations

The quality of life during intravesical bacillus Calmette-Guerin therapy.

1996 • 57 citations

The Quality of Life During Intravesical Bacillus Calmette-Guerin Therapy

1996 • 55 citations

Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.

2003 • 53 citations

Mitomycin c intravesical therapy in noninvasive bladder cancer after failure on thiotepa

1984 • 44 citations

INTERFERENCE OF MODERN ANTIBACTERIALS WITH BACILLUS CALMETTE-GUERIN VIABILITY

1999 • 34 citations

Bladder Wall Calcification after Intravesical Mitomycin C Treatment of Superficial Bladder Cancer

1989 • 33 citations

Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma

2005 • 25 citations

Cutaneous complications of intravesical treatments for bladder cancer: Granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy

2006 • 24 citations

Optimal Treatment of Systemic Bacillus Calmette-Guerin Infection: Investigations in an Animal Model

2002 • 24 citations

Bone Marrow Suppression after Intravesical Mitomycin C Treatment

1986 • 22 citations

Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette GuÉrin-induced bladder contractures

2005 • 22 citations

Transrectal Ultrasound Appearance of Prostatic Granulomas Secondary to Bacillus Calmette-Guerin Instillation

1997 • 17 citations

In Reply: Re: The Quality of Life During Intravesical Bacillus Calmette-Guerin Therapy

1996 • 15 citations

152 OFLOXACIN TO PREVENT BCG-INDUCED TOXICITY IN PATIENTS WITH SUPERFICIAL BLADDER CANCER: RESULTS OF A RANDOMISED PROSPECTIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE STUDY

2007 • 6 citations

Papillary-like bladder calcifications following intravescical mitomycin C. A case report.

1993 • 3 citations

PD-11.12

2006 • 3 citations